{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,11]],"date-time":"2024-04-11T17:53:14Z","timestamp":1712857994967},"reference-count":22,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.3892\/ol.2015.3539","type":"journal-article","created":{"date-parts":[[2015,7,28]],"date-time":"2015-07-28T11:16:12Z","timestamp":1438082172000},"page":"2051-2054","source":"Crossref","is-referenced-by-count":2,"title":["Imatinib-based therapy in adult Philadelphia chromosome-positive acute lymphoblastic leukemia: A case report and literature review"],"prefix":"10.3892","volume":"10","author":[{"given":"LI","family":"ZHANG","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MENG","family":"CHEN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"BO","family":"FENG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"PU","family":"KUANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"PENG","family":"HE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TING","family":"LIU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LING","family":"PAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2015,7,28]]},"reference":[{"key":"key20180108100315_b1-ol-0-0-3539","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.1182\/blood-2015-02-580043","article-title":"Redefining ALL classification: Toward detecting high-risk ALL and implementing precision medicine","volume":"125","author":"Hunger","year":"2015","journal-title":"Blood"},{"key":"key20180108100315_b2-ol-0-0-3539","doi-asserted-by":"crossref","first-page":"430","DOI":"10.3324\/haematol.2013.095562","article-title":"Management and treatment of osteonecrosis in children and adolescents with acute lymphoblastic leukemia","volume":"99","author":"TeWinkel","year":"2014","journal-title":"Haematologica"},{"key":"key20180108100315_b3-ol-0-0-3539","doi-asserted-by":"crossref","first-page":"381","DOI":"10.4103\/0973-1482.136664","article-title":"Rare presentation of pediatric acute promyelocytic leukemia as multiple lytic bone lesions: Case report and review of the literature","volume":"10","author":"Nair","year":"2014","journal-title":"J Cancer Res Ther"},{"key":"key20180108100315_b4-ol-0-0-3539","doi-asserted-by":"crossref","first-page":"3711","DOI":"10.1182\/blood-2015-02-627935","article-title":"Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL): Randomized study of reduced-intensity chemotherapy combined with imatinib in adults with Ph-positive acute lymphoblastic leukemia","volume":"125","author":"Chalandon","year":"2015","journal-title":"Blood"},{"key":"key20180108100315_b5-ol-0-0-3539","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/sj.leu.2404139","article-title":"Limited clinical value of regular bone marrow cytogenetic analysis in imatinib-treated chronic phase CML patients monitored by RQ-PCR for BCR-ABL","volume":"20","author":"Ross","year":"2006","journal-title":"Leukemia"},{"key":"key20180108100315_b6-ol-0-0-3539","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1182\/blood-2010-10-314682","article-title":"Mixed-phenotype acute leukemia: Clinical and laboratory features and outcome in 100 patients defined according to the WHO 2008 classification","volume":"117","author":"Matutes","year":"2011","journal-title":"Blood"},{"key":"key20180108100315_b7-ol-0-0-3539","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1002\/cncr.24862","article-title":"Adult acute lymphoblastic leukemia: Concepts and strategies","volume":"116","author":"Faderl","year":"2010","journal-title":"Cancer"},{"key":"key20180108100315_b8-ol-0-0-3539","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/pbc.24313","article-title":"Effectiveness of pamidronate as treatment of symptomatic osteonecrosis occurring in children treated for acute lymphoblastic leukemia","volume":"60","author":"Leblicq","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"key20180108100315_b9-ol-0-0-3539","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1097\/MPH.0b013e3181acd925","article-title":"Severe osteoporosis and high level TSH in a child before the diagnosis of acute lymphoblastic leukemia","volume":"31","author":"Atas","year":"2009","journal-title":"J Pediat Hematol Oncol"},{"key":"key20180108100315_b10-ol-0-0-3539","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/mpo.10295","article-title":"Marked osteoporosis and spontaneous vertebral fractures in children: Don't forget, it could be leukemia","volume":"41","author":"Bertuna","year":"2003","journal-title":"Med Pediatr Oncol"},{"key":"key20180108100315_b11-ol-0-0-3539","first-page":"88","article-title":"Extensive skeletal lesions in childhood acute lymphoblastic leukemia","volume":"18","author":"Hafiz","year":"2009","journal-title":"Mymensingh Med J"},{"key":"key20180108100315_b12-ol-0-0-3539","first-page":"130","article-title":"Back pain and vertebral compression: An unusual presentation of childhood acute lymphoblastic leukemia","volume":"19","author":"Hafiz","year":"2010","journal-title":"Mymensingh Med J"},{"key":"key20180108100315_b13-ol-0-0-3539","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.spinee.2006.04.013","article-title":"Osteoporotic compression fractures of the spine; current options and considerations for treatment","volume":"6","author":"Kim","year":"2006","journal-title":"Spine J"},{"key":"key20180108100315_b14-ol-0-0-3539","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1177\/107327481402100205","article-title":"Surgical management of primary and metastatic spinal tumors","volume":"21","author":"Kaloostian","year":"2014","journal-title":"Cancer Control"},{"key":"key20180108100315_b15-ol-0-0-3539","doi-asserted-by":"crossref","first-page":"e316","DOI":"10.1097\/MPH.0b013e318223fe9b","article-title":"Presentation and outcomes for children with bone marrow necrosis and acute lymphoblastic leukemia: A literature review","volume":"33","author":"Shah","year":"2011","journal-title":"J Pediatr Hematol Oncol"},{"key":"key20180108100315_b16-ol-0-0-3539","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s12185-012-1026-9","article-title":"Efficacy and safety of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed\/refractory Ph+ ALL: A 36-month analysis of a phase I and II study","volume":"95","author":"Usuki","year":"2012","journal-title":"Int J Hematol"},{"key":"key20180108100315_b17-ol-0-0-3539","doi-asserted-by":"crossref","first-page":"4396","DOI":"10.1182\/blood-2003-08-2958","article-title":"Treatment of Philadelphia chromosome-positive acute lymphocytic leukemia with hyper-CVAD and imatinib mesylate","volume":"103","author":"Thomas","year":"2004","journal-title":"Blood"},{"key":"key20180108100315_b18-ol-0-0-3539","doi-asserted-by":"crossref","first-page":"e72","DOI":"10.1038\/bcj.2012.18","article-title":"Prognostic factors influencing clinical outcome of allogeneic hematopoietic stem cell transplantation following imatinib-based therapy in BCR-ABL-positive ALL","volume":"2","author":"Mizuta","year":"2012","journal-title":"Blood Cancer J"},{"key":"key20180108100315_b19-ol-0-0-3539","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s11899-010-0061-y","article-title":"Changing paradigm of the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia","volume":"5","author":"Ohno","year":"2010","journal-title":"Curr Hematol Malig R"},{"key":"key20180108100315_b20-ol-0-0-3539","first-page":"612","article-title":"Dasatinib (Sprycel\u00ae) and Low Intensity Chemotherapy for First-Line Treatment in Patients with De Novo Philadelphia Positive ALL Aged 55 and Over: Final Results of the EWALL-Ph-01 Study","volume":"120","author":"Philippe","year":"2012","journal-title":"Blood (ASH Annual Meeting Abstracts)"},{"key":"key20180108100315_b21-ol-0-0-3539","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/leu.2010.228","article-title":"Pre-transplant imatinib-based therapy improves the outcome of allogeneic hematopoietic stem cell transplantation for BCR-ABL-positive acute lymphoblastic leukemia","volume":"25","author":"Mizuta","year":"2011","journal-title":"Leukemia"},{"key":"key20180108100315_b22-ol-0-0-3539","first-page":"1503","article-title":"Imatinib (IM) and interferon-alpha (IFN-\u03b1) maintenance therapy is associated with long-term DFS in a subset of elderly patients with Philadelphia-positive acute lymphoblastic leukemia (Ph ALL)","volume":"120","author":"Heike","year":"2012","journal-title":"Blood (ASH Annual Meeting Abstracts)"}],"container-title":["Oncology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ol.2015.3539\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T12:03:27Z","timestamp":1515413007000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ol.2015.3539"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,28]]},"references-count":22,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2015,7,28]]},"published-print":{"date-parts":[[2015,10]]}},"alternative-id":["10.3892\/ol.2015.3539"],"URL":"https:\/\/doi.org\/10.3892\/ol.2015.3539","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,28]]}}}